Table 3.
The expression of miR-211-3p in BCa is related to the patients’ TNM stage, tumor invasion stage and lymph node metastasis
| Clinicopathological data | Case | miR-211-3p expression | P | |
|---|---|---|---|---|
| High expression group (n = 28) | Low expression group (n = 34) | |||
| Age | 0.272 | |||
| 50 or less | 18 | 6 | 12 | |
| > 50 | 44 | 22 | 22 | |
| Gender | 0.117 | |||
| Male | 50 | 20 | 30 | |
| Female | 12 | 8 | 4 | |
| Tumor size (cm) | 0.118 | |||
| < 3.5 | 40 | 15 | 25 | |
| 3.5 or higher | 22 | 13 | 9 | |
| Tumor invasion stage (T) | < 0.001 | |||
| Tis/Ta/T1 | 34 | 22 | 12 | |
| T2/T3 or above | 28 | 6 | 22 | |
| TNM staging | 0.002 | |||
| 0/I | 33 | 21 | 12 | |
| II/III/IV | 29 | 7 | 22 | |
| Lymph node metastasis (N) | 0.006 | |||
| N0 | 47 | 26 | 21 | |
| N1 or more | 15 | 2 | 13 | |
| Pathological grade | 0.450 | |||
| Low | 28 | 11 | 17 | |
| High | 34 | 17 | 17 | |